Noelle K. Eder - 28 Feb 2025 Form 4 Insider Report for Cigna Group (CI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Mar 2025, 19:52:18 UTC
Prior SEC filing
07 Jan 2025
Next SEC filing
11 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Matthew Arnold, attorney-in-fact

Key filing fact

Noelle K. Eder filed Form 4 for Cigna Group (CI) on 04 Mar 2025.

Key facts

  • This page summarizes Noelle K. Eder's Form 4 filing for Cigna Group (CI).
  • 5 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 04 Mar 2025, 19:52.

Change

  • Previous filing in this sequence was filed on 07 Jan 2025.
  • Current net transaction value: -$1,413,991.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CI transaction

Common Stock, $.01 Par Value

Award

Transaction value
$0
Shares
+8,127
Change %
+49%
Price
$0.000000
Shares after
24,826
Date
28 Feb 2025
Ownership
Direct
Footnotes
F1
CI transaction

Common Stock, $.01 Par Value

Award

Transaction value
$0
Shares
+3,147
Change %
+13%
Price
$0.000000
Shares after
27,973
Date
28 Feb 2025
Ownership
Direct
Footnotes
F2
CI transaction

Common Stock, $.01 Par Value

Tax liability

Transaction value
$279,556
Shares
-914
Change %
-3.3%
Price
$305.86
Shares after
27,059
Date
28 Feb 2025
Ownership
Direct
Footnotes
F3
CI transaction

Common Stock, $.01 Par Value

Tax liability

Transaction value
$1,134,435
Shares
-3,709
Change %
-14%
Price
$305.86
Shares after
23,350
Date
28 Feb 2025
Ownership
Direct
Footnotes
F4
CI holding

Common Stock, $.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
183
Date
28 Feb 2025
Ownership
By 401(k)
Footnotes
F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CI transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+11,176
Change %
Price
$0.000000
Shares after
11,176
Date
28 Feb 2025
Ownership
Direct
Underlying class
Common Stock, $.01 Par Value
Underlying amount
11,176
Exercise price
$305.86
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Footnote F2

These restricted shares vest in three equal annual installments beginning March 1, 2026.

Footnote F3

Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Footnote F4

Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Footnote F5

Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

Footnote F6

This option vests in three equal annual installments beginning March 1, 2026.

SEC remarks

EVP, Global Chief Information Officer Exhibit List: EX-24 Power of Attorney poaeder.txt

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .